Arkema | AKE - Cost Of Sales

Stock Price
61.15
Daily Change
-0.95 -1.53%
Monthly
-1.37%
Yearly
-9.81%
Q2 Forecast
61.20

Arkema reported EUR1.8B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Air Products & Chemicals USD 2.18B 76.9M Mar/2026
Air Liquide EUR 5.9B 415.5M Dec/2025
Akzo Nobel EUR 1.41B 28M Mar/2026
Arkema EUR 1.8B 4.7M Mar/2026
BASF EUR 11.87B 941M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Covestro EUR 2.7B 5.39B Dec/2025
Croda International GBP 445.5M 221.15M Dec/2024
Givaudan CHF 2.07B 105M Dec/2025
IMCD EUR 873.57M 784.67M Dec/2024
Johnson Matthey GBP 5.04B 513M Dec/2025
Kemira EUR 564.4M 43.3M Jun/2025
Lenzing EUR 558.76M 75.84M Dec/2025
Linde USD 5.5B 1.12B Dec/2025
PPG Industries USD 2.45B 24M Dec/2025
Sika AG CHF 2.77B 49.8M Dec/2025
Solvay EUR 876M 16M Mar/2026
Umicore EUR 9.76B 1.54B Dec/2025